Massachusetts Financial Services’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.78M | Buy |
64,232
+793
| +1% | +$21.9K | ﹤0.01% | 774 |
|
|
2025
Q1 | $1.41M | Sell |
63,439
-1,442
| -2% | -$32K | ﹤0.01% | 782 |
|
|
2024
Q4 | $1.28M | Sell |
64,881
-1,935
| -3% | -$38.3K | ﹤0.01% | 793 |
|
|
2024
Q3 | $1.67M | Sell |
66,816
-1,618
| -2% | -$40.4K | ﹤0.01% | 747 |
|
|
2024
Q2 | $1.28M | Sell |
68,434
-7,049
| -9% | -$132K | ﹤0.01% | 779 |
|
|
2024
Q1 | $1.49M | Sell |
75,483
-167
| -0.2% | -$3.3K | ﹤0.01% | 752 |
|
|
2023
Q4 | $1.33M | Sell |
75,650
-2,392
| -3% | -$42K | ﹤0.01% | 750 |
|
|
2023
Q3 | $1.36M | Sell |
78,042
-2,990
| -4% | -$51.9K | ﹤0.01% | 747 |
|
|
2023
Q2 | $1.14M | Sell |
81,032
-1,909
| -2% | -$26.9K | ﹤0.01% | 740 |
|
|
2023
Q1 | $892K | Buy |
+82,941
| New | +$892K | ﹤0.01% | 769 |
|